GSK has been in the spotlight this year after being accused of paying almost$500m in bribes to doctors and health officials in China to boost prescribing of its drugs, with the resulting fall-out impacting its third-quarter financial results. Meanwhile, the company paid a massive $3bn settlement in the US in 2012 after pleading guilty to promoting drugs in unapproved uses and making unsupported safety claims for some of its products. Learn more about their new compensation system for reps here. (Source: PMLiVE, 12/17/13).
You are here: / / Can GSK Restore Its Reputation After Allegations Of Bribery?